Firstly, we are limited by the retrospective nature of the analysis; however, our data collection was comprehensive and included a substantial number of early stage patients in comparison to other published studies evaluating CXCR4 expression in lung cancer patients. The gene discussed is CXCR4; the disease is lung cancer.